MAPK14 and cervical carcinoma: Furthermore, knock down of MAPK1 or MAPK14 with two respective specific siRNAs did not significantly affect IL‐17‐induced resistance toward chemoradiotherapy in three tested cervical cancer cells (Fig. S3BC).